| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0043 | 0.9 |